AbbVie · 14 hours ago
Associate Scientist II, Biologics Drug Product Development
South San Francisco, CA
Full-time
Onsite
Mid Level
3+ years expAbbVie is dedicated to discovering and delivering innovative medicines that address serious health issues. The Associate Scientist II will be responsible for developing drug product formulations and conducting analytical assays for biologic therapeutics, while collaborating with a team to support pipeline programs.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Own & support stability / in-use / process studies: work within the process operations team to fill development drug product batches for GLP toxicology studies, reference standard fills, and representative drug product batches. Develop skills to plan and execute screening, in-use, and formulation stability studies to support formulation and process development for clinical trials
Perform analytical assays & support troubleshooting: conduct analytical assays to evaluate protein and excipients stability (i.e. HPLC/UPLC, SEC, CEX, CE‑SDS, icIEF, UV-Vis, CD, Karl Fischer titration, HIAC, MFI). Generate high-quality data to support selection of formulation composition, development of dose administration guidance, and drug product manufacturing instructions. Develop the skills to independently troubleshoot assays and instruments to ensure consistent quality data output
Analyze & communicate results: analyze study results, organize and document the results in an electronic lab notebook (ELN), and effectively communicate updates, troubleshooting, and results to the team. Interpret results and draw conclusions from multistage experiments with support from study owners and project leads. Communicate aberrant data and lab issues to management to gain input and alignment on solution
Write technical reports and communicate technical updates: Author technical reports to support regulatory filings and present the study results and findings to the team
Collaboration: Collaborate closely with highly matrixed team members to support pipeline programs and participate in project teams as a study owner
Qualification
Required
Degree in chemistry, chemical engineering, biochemistry, pharmaceutical sciences or equivalent
Bachelor's Degree with 3 or more years' experience or Master's Degree (no additional experience)
Strong technical background encompassing protein chemistry and protein handling
Hands-on experience with running and troubleshooting analytical techniques used for protein characterization and stability testing such as SEC, CEX, iCIEF, CE-SDS, HIAC, and MFI
Ability to work in cross-matrixed team supporting multiple projects and participate in project-focused teams
Technical ability to execute and troubleshoot experiments through rational and critical thinking. Must be highly organized and detail oriented
Eagerness to learn and apply new scientific techniques
Excellent verbal and written communication skills
Strong collaborative skills for working effectively within the team
Preferred
Prior experience in protein formulation development, process development, drug delivery, or analytical functions is highly preferred
Prior experience utilizing automated liquid handlers and/or executing high-throughput screening workflows is highly preferred
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
WSJ.com: US Business
2026-02-05
legacy.thefly.com
2026-02-05
2026-02-05
Company data provided by crunchbase